Angewandte Chemie

Unlocking the Potential of Machine Learning in Co‐crystal Prediction by a Novel Approach Integrating Molecular Thermodynamics

Yutong Song 1, 2
YEWEI DING 2, 3
Junyi Su 2, 3
Jian Li 4, 5
Yuanhui Ji 2, 6
2
 
Jiangsu Province Hi‐Tech Key Laboratory for Biomedical Research School of Chemistry and Chemical Engineering Southeast University Nanjing 211198 P.R. China
4
 
Jinling Pharmaceutical Co., Ltd. Jinling Pharmaceutical Co., Ltd. Nanjing CHINA
5
 
Jinling Pharmaceutical Co., Ltd. Nanjing 210009 P.R. China
6
 
Southeast University School of Chemistry and Chemical Engineering Moling Street, Jiangning District 211189 Nanjing CHINA
Publication typeJournal Article
Publication date2025-03-24
SJR
CiteScore
Impact factor
ISSN00448249, 15213757
Abstract

Co‐crystal engineering is of interest for many applications in pharmaceutical, chemical, and materials fields, but rational design of co‐crystals is still challenging. Although artificial intelligence has revolutionized decision‐making processes in material design, limitations in generalization and mechanistic understanding remain. Herein, we sought to improve prediction of co‐crystals by combining mechanistic thermodynamic modeling with machine learning. We constructed a brand‐new co‐crystal database, integrating drug, coformer, and reaction solvent information. By incorporating various thermodynamic models, the predictive performance was significantly enhanced. Benefiting from the complementarity of thermodynamic mechanisms and structural descriptors, the model coupling three thermodynamic models achieved optimal predictive performance in coformer and solvent screening. The model was rigorously validated against benchmark models using challenging independent test sets, showcasing superior performance in both coformer and solvent predicting with accuracy over 90%. Further, we employed SHAP analysis for model interpretation, suggesting that thermodynamic mechanisms are prominent in the model's decision‐making. Proof‐of‐concept studies on ketoconazole validated the model's efficacy in identifying coformers/solvents, demonstrating its potential in practical application. Overall, our work enhanced the understanding of co‐crystallization and highlighted the strategy that integrates mechanistic insights with data‐driven models to accelerate the rational design and synthesis of co‐crystals, as well as various other functional materials.

Liang X., Wu Y., Deng Y., Zeng X., Shan S., Jiang Y., Yang H.
Chemical Engineering Science scimago Q1 wos Q2
2024-11-01 citations by CoLab: 4 Abstract  
Multi-component crystal based on supramolecular self-assembly is an effective strategy to modify the physicochemical properties of poorly water-soluble drugs. In this study, eight novel multi-component crystals of Osimertinib (AZD) were firstly synthesized under the guidance of theoretical analysis. Five single crystals were successfully obtained, and the AZD-FMS cocrystal shows a distinctive structure wherein free FMS filled in the skeleton, which may be crucial for maintaining morphology. Analysis of crystal structures and Hirshfeld surfaces indicated the involvement of N−H···O and N···H−O hydrogen bonds in the multi-component crystals. Owing to robust intermolecular interactions, multi-component crystals exhibited improved solubility/dissolution rate compared to pure AZD. Multivariate analysis revealed coformers and strong solute–solvent interactions determined the solubility/dissolution rate. Multi-component crystals showed superior stability in solution and low humidity. Moreover, AZD-FSM increased 5.2-fold anti-tumor activity over AZD, which is anticipated to enhance efficacy, reduce drug toxicity, combat drug resistance, and transform from laboratory to clinical application.
Muravyev N.V., Fershtat L., Zhang Q.
Chemical Engineering Journal scimago Q1 wos Q1
2024-04-01 citations by CoLab: 28 Abstract  
Energetic materials are important class of functional compounds that combine the beauty of extreme high-energy chemistry with rigorous constraints on safety and performance. As a result, the development of energetic materials is a challenging process that require the best of computational, chemical synthesis, and material design techniques. This review discusses the state-of-art of the energetics field, and then highlights the most recent synthetic advancements that go beyond – regioisomerism impact, almost all-nitrogen species, new mesoionic ring fragments, and compounds bearing elements other than traditional CHNO. The computational advancements are summarized further: the material genome approaches and high-throughput virtual screening. Next, the material science and crystal engineering design tools are reviewed, from cocrystal design and host-guest inclusion to various polymer coating techniques. Overall, we showcase the complexity of interdisciplinary problem of energetic materials design, that entraps the original mostly organic chemical field, but then material science and crystal engineering, and now targets the computational discovery and machine learning.
Singh M., Shen K., Ye W., Gao Y., Lv A., Liu K., Ma H., Meng Z., Shi H., An Z.
2024-02-27 citations by CoLab: 40 Abstract  
AbstractOrganic phosphors offer a promising alternative in optoelectronics, but their temperature‐sensitive feature has restricted their applications in high‐temperature scenarios, and the attainment of high‐temperature phosphorescence (HTP) is still challenging. Herein, a series of organic cocrystal phosphors are constructed by supramolecular assembly with an ultralong emission lifetime of up to 2.16 s. Intriguingly, remarkable stabilization of triplet excitons can also be realized at elevated temperature, and green phosphorescence is still exhibited in solid state even up to 150 °C. From special molecular packing within the crystal lattice, it has been observed that the orientation of isolated water cluster and well‐controlled molecular organization via multiple interactions can favor the structural rigidity of cocrystals more effectively to suppress the nonradiative transition, thus resulting in efficient room‐temperature phosphorescence and unprecedented survival of HTP.
Molajafari F., Li T., Abbasichaleshtori M., Hajian Z. D. M., Cozzolino A.F., Fandrick D.R., Howe J.D.
CrystEngComm scimago Q2 wos Q1
2024-02-23 citations by CoLab: 11 Abstract  
COSMO-RS and machine learning-based models can reduce the cost of screening and identifying crystal coformers, facilitating discovery of new cocrystals.
Manin A.N., Boycov D.E., Simonova O.R., Drozd K.V., Volkova T.V., Perlovich G.L.
Crystal Growth and Design scimago Q2 wos Q1
2023-11-30 citations by CoLab: 10
Yang D., Wang L., Yuan P., An Q., Su B., Yu M., Chen T., Hu K., Zhang L., Lu Y., Du G.
Chinese Chemical Letters scimago Q1 wos Q1
2023-08-01 citations by CoLab: 23 Abstract  
Co-crystal formation can improve the physicochemical properties of a compound, thus enhancing its druggability. Therefore, artificial intelligence-based co-crystal virtual screening in the early stage of drug development has attracted extensive attention from researchers. However, the complexity of developing and applying algorithms hinders it wide application. This study presents a data-driven co-crystal prediction method based on the XGBoost machine learning model of the scikit-learn package. The simplified molecular input line entry specification (SMILES) information of two compounds is simply inputted to determine whether a co-crystal can be formed. The data set includs the co-crystal records presented in the Cambridge Structural Database (CSD) and the records of no co-crystal formation from extant literature and experiments. RDKit molecular descriptors are adopted as the features of a compound in the data set. The developed model shows excellent performance in the proposed co-crystal training and validation sets with high accuracy, sensitivity, and F1 score. The prediction success rate of the model exceeds 90%. The model therefore provides a simple and feasible scheme for designing and screening co-crystal drugs efficiently and accurately. This study presents a data-driven co-crystal prediction method based on the XGBoost machine learning model. The simplified molecular input line entry specification information of two compounds is simply inputted to determine whether a co-crystal can be formed. The prediction success rate of the model exceeds 90%. The model therefore provides a simple and feasible scheme for designing and screening co-crystal drugs efficiently and accurately.
Shen P., Zhang C., Hu E., Gao Y., Wei Y., Zhang J., Qian S., Heng W.
Molecular Pharmaceutics scimago Q1 wos Q1
2023-05-30 citations by CoLab: 5
Shen Y., Cruz-Cabeza A.J., Azzouz O., Edkins K.
Molecular Pharmaceutics scimago Q1 wos Q1
2023-03-21 citations by CoLab: 6
Xia M., Jiang Y., Cheng Y., Dai W., Rong X., Zhu B., Mei X.
2023-01-01 citations by CoLab: 15 Abstract  
Rucaparib (Ruc) is a drug used to treat advanced ovarian cancer associated with deleterious BRCA mutations. Its commercial form, the camsylate salt (Ruc-Cam), suffers from poor aqueous solubility and thus causes low and erratic oral bioavailability. In this work, we aimed to improve the oral exposure of Ruc through cocrystallization. Liquid-assisted grinding, slurry, and solvent evaporation methods were employed to prepare new solid forms of Ruc. Cocrystals of rucaparib-theophylline monohydrate (Ruc-Thp MH), rucaparib-maltol (Ruc-Mal), and rucaparib-ethyl maltol (Ruc-Emal) were obtained. Powder X-ray diffraction, Fourier transform infrared spectroscopy, thermogravimetric analysis, differential scanning calorimetry, and dynamic vapor sorption were utilized to characterize these multi-component systems. All cocrystals dissolve faster than Ruc-Cam at pH 2.0 and 4.5, and Ruc-Thp MH displays the highest apparent solubility in pH 4.5 and 6.8 buffers. Pharmacokinetic studies in rats show that Ruc-Thp MH exhibits 2.4 times the Cmax and 1.4 times the AUC0-24h at a single dose compared with Ruc-Cam. The enhanced solubility and bioavailability of Ruc-Thp MH showcase the power of cocrystallization in addressing absorption issues in drug development.
Alhadid A., Jandl C., Mokrushina L., Minceva M.
Journal of Molecular Liquids scimago Q1 wos Q1
2022-12-01 citations by CoLab: 13 Abstract  
• The solid–liquid phase diagram of five L-menthol/xylenol eutectic systems was measured. • Three cocrystals were observed in the studied eutectic systems, and a new 3,4-xylenol polymorph was identified. • L-menthol does not form cocrystals with xylenol isomers bearing a methyl group at position 2. • COSMO-RS with the TZVP and TZVPD_FINE parameterizations was used to predict the phase diagrams. • COSMO-RS predicts well the eutectic points of the studied systems. Nonideality and cocrystal formation affect the solid–liquid equilibria (SLE) in eutectic systems. This study investigates the influence of the molecular structure of xylenol (dimethylphenol) isomers on the nonideality and cocrystal formation in eutectic systems containing L-menthol and five different xylenol isomers. Differential scanning calorimetry and powder X-ray diffraction analyses were employed to comprehend the SLE phase diagram of the studied systems. L-Menthol did not form cocrystals with xylenol isomers having a methyl group at position 2. In contrast, two cocrystals were observed in the L-menthol/3,4-xylenol systems at 1:2 and 2:1 ratios, and one cocrystal was observed in the 1:1 L-menthol/3,5-xylenol system. The liquid phase of all systems showed a strong negative deviation from ideality, except the L-menthol/2,6-xylenol eutectic system, which exhibited a near-ideal behavior. The nonideality of the liquid phase was modeled using the conductor-like screening model for realistic solvation (COSMO-RS) using TZVP and TZVPD_FINE parameterizations, finding that COSMO-RS can reasonably describe the liquid phase nonideality and predict the SLE phase diagram of simple eutectic systems and systems with cocrystal formation.
Hao Y., Hung Y.C., Shimoyama Y.
Crystal Growth and Design scimago Q2 wos Q1
2022-10-24 citations by CoLab: 17
Banerjee M., Nimkar K., Naik S., Patravale V.
Journal of Controlled Release scimago Q1 wos Q1
2022-08-01 citations by CoLab: 36 Abstract  
Intensive research subjected to the improvement of solubility and bioavailability of certain drugs has popularized the formation of cocrystals, wherein the desired drug is non-ionically bonded to a coformer by means of weak bonds. This paper addresses how crystal engineering of two compatible drug components can enhance the physicochemical and therapeutic properties of either or both of the drugs, resulting in drug-drug cocrystals, with pertinent examples. The paper also discusses the continuous screening processes which are replacing the traditional methods of crystallization due to numerous benefits to the producer as well as the products. Although faced with certain regulatory and scale-up constraints, cocrystals provide immense opportunities to the field of novel drug development.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST | RIS | BibTex
Found error?